A Study of Caspofungin (MK-0991) in Japanese Children & Adolescents With

See also
Status	Clinical Trial	Phase
Suspended	`NCT01887457` - Individualisation of Voriconazole Antifungal Therapy Antifungal Therapy	Phase 2
Completed	`NCT00940017` - A Study To Assess The Anidulafungin And Voriconazole Concentration In Lung Following Intravenous Administration In Healthy Subjects	Phase 4
Enrolling by invitation	`NCT01617759` - Aspergillus-specific PCR Assay in Cerebrospinal Fluid Samples for Detection of Central Nervous System Aspergillosis
Terminated	`NCT03905447` - The Effect of Early Treatment of PC945 on Aspergillus Fumigatus Lung Infection in Lung Transplant Patients.	Phase 2
Recruiting	`NCT04744454` - Post Marketing Surveillance (PMS) Study of Cresemba in Korea.
Completed	`NCT02715570` - A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of PC945	Phase 1
Withdrawn	`NCT01622595` - UARK 2009-99 A Non-interventional Observational Study of Infectious Complications in Cancer Patients	N/A
Completed	`NCT00001937` - Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant Patients	Phase 3
Completed	`NCT04935463` - Mucormycosis in COVID-19
Withdrawn	`NCT01188759` - Voriconazole And Anidulafungin Combination For Invasive Aspergillosis In Pediatric Subjects	Phase 3
Completed	`NCT00473252` - Surveillance of Fungal Infections During Construction Activity	N/A
Completed	`NCT00037206` - A Safety & Effectiveness Study of Intravenous Anidulafungin With AmBisome® for Treatment of Invasive Aspergillosis (IA).	Phase 2/Phase 3
Completed	`NCT04818853` - COVID-19 Associated Pulmonary Aspergillosis (CAPA) and Other Invasive Fungal Infections (IFI)
Completed	`NCT00412893` - Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis	Phase 3
Recruiting	`NCT06135597` - Immune Regulation in Chronic Aspergillus Infection After COVID-19 Infection
Terminated	`NCT02646800` - Post Marketing Study to Evaluate the Safety and Efficacy of Micafungin Against Fungal Infections Caused by Candida Spp or Aspergillus Spp	Phase 4
Completed	`NCT00854607` - An Observational Study of Fungal Biomarkers (MK-0000-089)	N/A
Completed	`NCT00388167` - Acetato de Caspofungin (Cancidas®) in the Treatment of Fungal Infection	Phase 4
Completed	`NCT05065658` - Posaconazole Prophylaxis for CAPA Prevention in Critically-Ill Patients
Completed	`NCT00005912` - Voriconazole to Prevent Systemic Fungal Infections in Children	Phase 1

NCT number	NCT01165320
Study type	Interventional
Source	Merck Sharp & Dohme Corp.
Contact
Status	Completed
Phase	Phase 2
Start date	July 6, 2010
Completion date	September 17, 2013

A Study of Caspofungin (MK-0991) in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections (MK-0991-074)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms